Saturday, November 18, 2023 6:43:15 AM
What do you guys think about Enobosarm from Veru as a potential supplement of GLP-1 to prevent muscle loss!
Their presentations is here
https://d1io3yog0oux5.cloudfront.net/_4f136a8e165011094eacac2cb4ac2887/verupharma/db/2224/21018/pdf/Veru+Corporate+Deck+-+November+2023.pdf
Versanis(Bimagrumab, Anti-myostatin) was acquired by Lillyl for 2B july 2023 and BioAge(Azelaprag, Apelin receptor agonist) has started studying with Lilly, which looks like Lilly is looking for a drug to prevent muscle loss.
Muscle loss looks like serious side effect in the trial refer to the below picture
Enobosarm is the only hormone therapy and oral drug, which is significant advantage.
Moreover, They've already done phase-3 trial on muscle wasting in patients with NSCLC
If they show great result on the phase-2 study, It will be fantastic stock. cuz market cap of Veru is only 96.15m
I hope to hear you guys thoughts! thank you in advance
Their presentations is here
https://d1io3yog0oux5.cloudfront.net/_4f136a8e165011094eacac2cb4ac2887/verupharma/db/2224/21018/pdf/Veru+Corporate+Deck+-+November+2023.pdf
Versanis(Bimagrumab, Anti-myostatin) was acquired by Lillyl for 2B july 2023 and BioAge(Azelaprag, Apelin receptor agonist) has started studying with Lilly, which looks like Lilly is looking for a drug to prevent muscle loss.
Muscle loss looks like serious side effect in the trial refer to the below picture
Enobosarm is the only hormone therapy and oral drug, which is significant advantage.
Moreover, They've already done phase-3 trial on muscle wasting in patients with NSCLC
If they show great result on the phase-2 study, It will be fantastic stock. cuz market cap of Veru is only 96.15m
I hope to hear you guys thoughts! thank you in advance
Discover What Traders Are Watching
Explore small cap ideas before they hit the headlines.
